Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancer.

Korangath P, Barnett JD, Sharma A, Henderson ET, Stewart J, Yu SH, Kandala SK, Yang CT, Caserto JS, Hedayati M, Armstrong TD, Jaffee E, Gruettner C, Zhou XC, Fu W, Hu C, Sukumar S, Simons BW, Ivkov R.

Sci Adv. 2020 Mar 25;6(13):eaay1601. doi: 10.1126/sciadv.aay1601. eCollection 2020 Mar.

PMID:
32232146
2.

Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles.

Sharma A, Cornejo C, Mihalic J, Geyh A, Bordelon DE, Korangath P, Westphal F, Gruettner C, Ivkov R.

Sci Rep. 2018 Mar 20;8(1):4916. doi: 10.1038/s41598-018-23317-2.

3.

Correlation between physical structure and magnetic anisotropy of a magnetic nanoparticle colloid.

Dennis CL, Jackson AJ, Borchers JA, Gruettner C, Ivkov R.

Nanotechnology. 2018 May 25;29(21):215705. doi: 10.1088/1361-6528/aab31d. Epub 2018 Mar 1.

PMID:
29493534
4.

Fucoidan Prolongs the Circulation Time of Dextran-Coated Iron Oxide Nanoparticles.

Abdollah MRA, Carter TJ, Jones C, Kalber TL, Rajkumar V, Tolner B, Gruettner C, Zaw-Thin M, Baguña Torres J, Ellis M, Robson M, Pedley RB, Mulholland P, T M de Rosales R, Chester KA.

ACS Nano. 2018 Feb 27;12(2):1156-1169. doi: 10.1021/acsnano.7b06734. Epub 2018 Jan 17.

PMID:
29341587
5.

An optimised spectrophotometric assay for convenient and accurate quantitation of intracellular iron from iron oxide nanoparticles.

Hedayati M, Abubaker-Sharif B, Khattab M, Razavi A, Mohammed I, Nejad A, Wabler M, Zhou H, Mihalic J, Gruettner C, DeWeese T, Ivkov R.

Int J Hyperthermia. 2018 Jun;34(4):373-381. doi: 10.1080/02656736.2017.1354403. Epub 2017 Jul 31.

6.

Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study.

Attaluri A, Seshadri M, Mirpour S, Wabler M, Marinho T, Furqan M, Zhou H, De Paoli S, Gruettner C, Gilson W, DeWeese T, Garcia M, Ivkov R, Liapi E.

Int J Hyperthermia. 2016 Aug;32(5):543-57. doi: 10.3109/02656736.2016.1159737. Epub 2016 May 5.

7.

Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo.

Shanehsazzadeh S, Gruettner C, Lahooti A, Mahmoudi M, Allen BJ, Ghavami M, Daha FJ, Oghabian MA.

Contrast Media Mol Imaging. 2015 May-Jun;10(3):225-36. doi: 10.1002/cmmi.1627. Epub 2014 Oct 18.

8.

Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen.

Shahbazi-Gahrouei D, Abdolahi M, Zarkesh-Esfahani SH, Laurent S, Sermeus C, Gruettner C.

Biomed Res Int. 2013;2013:349408. doi: 10.1155/2013/349408. Epub 2012 Dec 31.

9.

The effect of cell cluster size on intracellular nanoparticle-mediated hyperthermia: is it possible to treat microscopic tumors?

Hedayati M, Thomas O, Abubaker-Sharif B, Zhou H, Cornejo C, Zhang Y, Wabler M, Mihalic J, Gruettner C, Westphal F, Geyh A, Deweese TL, Ivkov R.

Nanomedicine (Lond). 2013 Jan;8(1):29-41. doi: 10.2217/nnm.12.98. Epub 2012 Nov 22.

10.

Preliminary study of injury from heating systemically delivered, nontargeted dextran-superparamagnetic iron oxide nanoparticles in mice.

Kut C, Zhang Y, Hedayati M, Zhou H, Cornejo C, Bordelon D, Mihalic J, Wabler M, Burghardt E, Gruettner C, Geyh A, Brayton C, Deweese TL, Ivkov R.

Nanomedicine (Lond). 2012 Nov;7(11):1697-711. doi: 10.2217/nnm.12.65. Epub 2012 Jul 26.

11.

NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics.

Natarajan A, Gruettner C, Ivkov R, DeNardo GL, Mirick G, Yuan A, Foreman A, DeNardo SJ.

Bioconjug Chem. 2008 Jun;19(6):1211-8. doi: 10.1021/bc800015n. Epub 2008 Jun 3.

12.

Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells.

Lehmann J, Natarajan A, Denardo GL, Ivkov R, Foreman AR, Catapano C, Mirick G, Quang T, Gruettner C, Denardo SJ.

Cancer Biother Radiopharm. 2008 Apr;23(2):265-71. doi: 10.1089/cbr.2007.0411.

PMID:
18454696
13.

Development of multivalent radioimmunonanoparticles for cancer imaging and therapy.

Natarajan A, Xiong CY, Gruettner C, DeNardo GL, DeNardo SJ.

Cancer Biother Radiopharm. 2008 Feb;23(1):82-91. doi: 10.1089/cbr.2007.0410.

PMID:
18298332
14.

Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice.

DeNardo SJ, DeNardo GL, Natarajan A, Miers LA, Foreman AR, Gruettner C, Adamson GN, Ivkov R.

J Nucl Med. 2007 Mar;48(3):437-44.

15.

Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.

DeNardo SJ, DeNardo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, Adamson GN, Ivkov R.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7087s-7092s.

Supplemental Content

Loading ...
Support Center